Boiron SA (EPA:BOI)

France flag France · Delayed Price · Currency is EUR
27.40
+0.45 (1.67%)
At close: Feb 27, 2026
9.60%
Market Cap 475.73M
Revenue (ttm) 504.86M
Net Income (ttm) 19.37M
Shares Out 17.36M
EPS (ttm) 1.12
PE Ratio 24.56
Forward PE 17.55
Dividend 1.20 (4.45%)
Ex-Dividend Date Jun 3, 2025
Volume 631
Average Volume 1,279
Open 26.80
Previous Close 26.95
Day's Range 26.80 - 27.40
52-Week Range 20.85 - 32.25
Beta 0.30
RSI 39.43
Earnings Date Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a... [Read more]

Sector Healthcare
Founded 1932
Employees 2,736
Stock Exchange Euronext Paris
Ticker Symbol BOI
Full Company Profile

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial Statements

News

There is no news available yet.